R. Hunter

Discovery of 5-[[4-[(2,3-Dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor

Philip A. Harris, Amogh Boloor, Mui Cheung et al. · Journal of Medicinal Chemistry · 2008 · 342 citations · Full text

Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2):  Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis

H. Neal Bramson, J. Corona, Stephen T. Davis et al. · Journal of Medicinal Chemistry · 2001 · 267 citations · Full text

Oxindole-based Inhibitors, Oxindole-based Compounds, Ligand Docking +16

The discovery of potent cRaf1 kinase inhibitors

Karen Lackey, Michael Cory, Ronda G. Davis et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 205 citations · Full text

Drug Target, Medicine, Receptor Tyrosine Kinase +3

Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors

Stephen T. Davis, Bill Benson, H. Neal Bramson et al. · Science · 2001 · 167 citations

Cdk Inhibitors, Chemoprevention Strategy, Hair Loss +11

Discovery and Evaluation of 2-Anilino-5-aryloxazoles as a Novel Class of VEGFR2 Kinase Inhibitors

Philip A. Harris, Mui Cheung, R. Hunter et al. · Journal of Medicinal Chemistry · 2005 · 135 citations · Full text